increased IgG2a level_Cd22<tm1Msn>/Cd22<tm1Msn>

http://metadb.riken.jp/0008500EI129SSvEvBALBcorI129SSvEvC57BL6JCd22tm1MsnCd22tm1MsnCd22tm1Msn

increased IgG2a level_Cd22<tm1Msn>/Cd22<tm1Msn>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• CD22 antigen
  http://metadb.riken.jp/db/mgi_rdf/MGI:88322

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cd22<tm1Msn>/Cd22<tm1Msn>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cd22<tm1Msn>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• either: (involves: 129S/SvEv * BALB/c) or (involves: 129S/SvEv * C57BL/6J)

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased IgG2a level
  http://purl.obolibrary.org/obo/MP_0008500

文献

http://purl.org/net/cito/citesAsAuthority

• T L. O'Keefe, et.al., Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies., The Journal of experimental medicine, 1999, 189
  http://rdf.ncbi.nlm.nih.gov/pubmed/10209047